Showing results (1-10 of 388) with videos related to

Sort By:
Pageof 39
Metabolic Bone Disease & Related Research|January 1, 1984
Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's diseaseM L Smith, I Fogelman, S Ralston, et al.
Lancet (London, England)|April 14, 1984
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's diseaseB F Boyce, L Smith, I Fogelman, et al.
Scottish Medical Journal|January 1, 1980
The bone scan in clinical practiceI Fogelman, I T Boyle
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1987
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical studyS H Ralston, B F Boyce, R A Cowan, et al.
Metabolic Bone Disease & Related Research|January 1, 1981
The role of bone scanning in Paget's diseaseI Fogelman, D Carr, I T Boyle
Lancet (London, England)|November 6, 1982
Hypercalcaemic osteomalacia due to aluminium toxicityB F Boyce, G S Fell, H Y Elder, et al.
Radiology|October 1, 1984
Bone scan appearances following biopsy of bone and bone marrowJ H McKillop, D Maharaj, B F Boyce, et al.
Lancet (London, England)|October 23, 1982
Hypercalcaemia and metastatic bone disease: is there a causal link?S Ralston, I Fogelman, M D Gardner, et al.
British Medical Journal (Clinical Research Ed.)|May 12, 1984
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancyS H Ralston, I Fogelman, M D Gardiner, et al.
European Journal of Nuclear Medicine|December 30, 1977
Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeletonI Fogelman, J H McKillop, I T Boyle, et al.
Pageof 39